3iQ Corp. announced that it is launching 3iQ Global Cryptoasset Fund which will be available to accredited investors, advisors and dealers via Fundserv, and to pension funds, institutions and family offices via private placement. The fund, structured as a Trust, will invest directly in bitcoin, ether and litecoin, three of the leading cryptoassets.
3iQ aims to launch and complete its first close within the next few weeks.
3iQ has been approved by the Ontario Securities Commission (OSC) and the Canadian Securities Administrators (CSA) as Portfolio Manager and Investment Fund Manager permitted to invest in multiple crypto assets. The registration with OSC was effective January 16, 2018.
“We have worked diligently to provide a pure, low-cost, secure method for both accredited and institutional investors to assume a core position in this new and expanding asset class. Although an exempt market product, we at 3iQ are excited to offer this product with our partners and to bring a diversified basket of leading digital assets to institutions and qualified investors,” said 3iQ Chief Executive Officer Frederick Pye.
Unique to the fund and to 3iQ in general in Canada, are relationships which include lead consultancy from ARK-Invest of New York, an institutional level of security with a leading cryptoasset Custodian, and expert trading with established trading firms to access liquidity across the entire cryptoasset space, added Pye.
Founded in 2012, 3iQ is focused on providing innovative investments of institutional quality in disruptive technologies and the crypto asset space.
photo credit: The-Contributor via pixabay
Ted is the architect of CVCA infobase, and is the architect of CPE Media's Financings.ca, Canada's most sophisticated and advanced all private capital and public market financing database.
Latest posts by Ted Liu (see all)
- Link Global Technologies files for $1.5M IPO on CSE - January 17, 2019
- Altas Partners sells NSC Minerals to PE-backed Kissner Group - January 17, 2019
- K1 Investment’s PerfectServ acquires Telmediq - January 17, 2019